Table 2.
Prevalence of components in causal pathways
| Component | % of total population | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neuropathy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 93·1 | ||||||
| Deformity | x | x | x | x | x | x | x | x | x | x | x | x | x | 63·1 | |||||||||||
| Callus | x | x | x | x | x | x | x | x | x | x | x | x | 60·2 | ||||||||||||
| Pressure | x | x | x | x | x | x | x | x | x | x | 52·4 | ||||||||||||||
| Vascular disease* | x | x | x | x | x | x | x | 23·3 | |||||||||||||||||
| Ill‐fitting shoes* | x | x | x | x | x | 19·4 | |||||||||||||||||||
| Puncture injury* | x | 10·7 | |||||||||||||||||||||||
| % of all pathways | 20·4 | 10·7 | 8·7 | 7·8 | 5·8 | 5·8 | 4·9 | 3·9 | 3·9 | 3·9 | 3·9 | 2·9 | 2·9 | 2·9 | 1·9 | 1·9 | 1·0 | 1·0 | 1·0 | 1·0 | 1·0 | 1·0 | 1·0 | 1·0 | |
Pivotal event.